NAD+ Peptides and Therapy: Benefits, Injections, and What the Research Shows

Why NAD+ Levels Decline With Age

NAD+ is synthesized from tryptophan and niacin (vitamin B3) through multiple biochemical pathways. Levels decline with age for several interconnected reasons:

• Increased consumption: DNA damage accumulates with age, activating PARP enzymes that consume NAD+ for repair. Chronic inflammation ("inflammaging") similarly depletes NAD+.
• Reduced synthesis: The salvage pathway (which recycles NAD+ precursors) becomes less efficient with age, and expression of the rate-limiting enzyme NAMPT declines.
• CD38 upregulation: CD38 (an enzyme that degrades NAD+) increases with aging and inflammation. This creates a self-reinforcing cycle: inflammation → CD38 ↑ → NAD+ ↓ → mitochondrial dysfunction → more inflammation.

Studies show a 50% or greater decline in NAD+ levels between age 40 and 70 in most tissues studied. Whether restoring NAD+ to youthful levels translates to measurable clinical improvements remains the subject of active research.

NAD+ Delivery Methods: Comparison

What the Human Research Shows

Most NAD+ research showing dramatic anti-aging effects has been done in mice and cells. Human clinical evidence is more modest but growing:

• NR supplementation: Multiple Phase II trials confirm that NR reliably raises blood NAD+ levels 40–90% in older adults. A 2018 Cell Metabolism study showed NR (1g/day) raised NAD+ by 60% in healthy older adults without significant side effects.
• NMN supplementation: A 2023 randomized controlled trial (Nature Aging) showed NMN increased muscle NAD+ levels and improved muscle performance in older men. A 2022 RCT showed NMN improved walking speed and grip strength in older Japanese adults.
• IV NAD+: Anecdotal reports of improved energy, clarity, and reduced cravings (especially from addiction recovery contexts) are common, but large RCTs are lacking. The clinical use of IV NAD+ for addiction and mood disorders has the most documented case experience.
• Longevity outcomes: No human study has yet demonstrated that NAD+ supplementation extends lifespan or prevents age-related disease. The mouse data is compelling; the translation to humans is unproven.

NAD+ in Peptide Stacks

NAD+ is frequently combined with peptides in anti-aging protocols because the mechanisms are complementary:

• NAD+ + Epithalon: Epithalon activates telomerase (telomere extension); NAD+ activates sirtuins (epigenetic maintenance) and supports DNA repair. These address different aspects of cellular aging.
• NAD+ + BPC-157: BPC-157 activates GH/VEGF/NO pathways for tissue repair. NAD+ provides mitochondrial energy substrate. The combination is used by some longevity practitioners for tissue repair plus cellular energy optimization.
• NAD+ + GH secretagogues: Growth hormone increases IGF-1 which regulates cell growth; NAD+ supports mitochondrial efficiency. These complement each other for body composition and anti-aging goals.

These stack rationales are largely theoretical — the combination protocols lack controlled clinical trial evidence. However, each component has its own evidence base, and the mechanisms are biologically coherent.